Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Edgewise Therapeutics Inc., 3 years.
Edgewise Therapeutics Inc.
Director
Corvus Pharmaceuticals Inc.
Director
ARS Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 26, 2024 | ARS Pharmaceuticals Inc. | Open-market sale | −83,695 | $13.00 | $1,088,035 |
| Aug 23, 2024 | ARS Pharmaceuticals Inc. | Open-market sale | −69,500 | $13.03 | $905,585 |
| Aug 22, 2024 | ARS Pharmaceuticals Inc. | Open-market sale | −391,482 | $12.94 | $5,065,777 |
| Aug 21, 2024 | ARS Pharmaceuticals Inc. | Open-market sale | −394,400 | $13.52 | $5,332,288 |
| Aug 21, 2024 | ARS Pharmaceuticals Inc. | Open-market sale | −13,300 | $14.61 | $194,313 |
| Jan 23, 2024 | Edgewise Therapeutics Inc. | Open-market purchase | +454,545 | $11.00 | $4,999,995 |
| Aug 29, 2023 | ARS Pharmaceuticals Inc. | Open-market purchase | +500,000 | $6.20 | $3,100,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.